138. Nerve cell migration disorder Disease details / Clinical trials / Drug dev / DR info /
Clinical trials : 2 / Drugs : 3 - (DrugBank : 2) / Drug target gene : 1 - Drug target pathways : 103
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Alpelisib
Centre Hospitalier Universitaire Dijon
2022 Phase 2 NCT05577754 France
Optional lumbar puncture + blood sample
Centre Hospitalier Universitaire Dijon
2022 Phase 2 NCT05577754 France
RLY-2608
Relay Therapeutics, Inc.
2025 Phase 2 NCT06789913 United States
Centre Hospitalier Universitaire Dijon
2022 Phase 2 NCT05577754 France
Optional lumbar puncture + blood sample
Centre Hospitalier Universitaire Dijon
2022 Phase 2 NCT05577754 France
RLY-2608
Relay Therapeutics, Inc.
2025 Phase 2 NCT06789913 United States